ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bullishFadu
25 Sep 2023 17:33

KOSDAQ 150 Rebalance Candidates in December 2023

In this insight, we discuss the potential inclusion and exclusion candidates for the KOSDAQ 150 rebalance in December 2023.

Logo
612 Views
Share
bullishHLB Inc
28 Aug 2023 14:00

Positioning for the Timing of HLB, the Latest Target in the KOSDAQ Exodus

This post explores why top KOSDAQ companies are hurrying to shift to KOSPI in the second half of this year and discusses the best timing for...

Logo
621 Views
Share
20 Aug 2023 07:19

Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
599 Views
Share
bullishJapan Post Bank
20 Aug 2023 07:05

Last Week in Event SPACE: Aussie Tax-Loss Selling, Japan Post Bank/Holdings, AviChina, Hang Lung

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
565 Views
Share
bullishCelltrion Inc
20 Aug 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Celltrion, Sanei Architecture, T&K Toka, MPI, Chindata

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
527 Views
Share
x